Explore our Resources
Access a curated collection of materials designed to provide insights into our capabilities and expertise across the drug development and manufacturing lifecycle.
Resources
Whitepaper
Beyond the Molecule: Human Factors Engineering as the Competitive Edge in Drug-Device Combination Products
The molecule isn’t the differentiator anymore. The device is. What this whitepaper covers: How an integrated CDMO turns device usability into commercial advantage for self-administered drug-device combination products. Whitepaper Abstract: For a…
Industry Perspective
Cyber Risk is now a financial risk: Why pharma boards can’t look away
Anurag Bhagania, CFO, OneSource Specialty Pharma Published on ET Edge Insights Source: Cyber Risk is now a financial risk: Why pharma boards can’t look away – ET Edge Insights Cyber risk is…
Whitepaper
Lyophilization by Design: Engineering Stability, Speed, and Scale into the Next Generation of Parenteral Products
What this whitepaper covers: Why lyophilization has become a defining constraint in modern biologics development — and how a QbD-led, integrated approach transforms cycle design into a scalable, regulatory-ready system. Whitepaper Abstract:…
Industry Perspective
The quiet revolution in how we take our medicine
The quiet revolution in how we take our medicine Ravi Kumar, Global Head of Injectables & Corporate Strategy, Portfolio and SPO Published on Money Control, 05 Jun 2026 Three out of four…
Whitepaper
Bioavailability by Design: Lipid Softgel Technology as a Commercial Rescue Path for Poorly Soluble, Low-Bioavailability Molecules
Solubility is broken. The pipeline proves it. What this whitepaper covers: Why solubility failure is the defining challenge of modern oral drug development — and how self-emulsifying softgel technology (SEDDS/SMEDDS/SNEDDS) unlocks bioavailability…
Whitepaper
Driving the Shift to Subcutaneous Biologics
The subcutaneous shift has already happened. Is your pipeline ready? In 2000–2004, 25% of FDA biologic approvals were device-based. By 2023-2025, 74% were. OneSource delivers the complete subcutaneous (SC) development stack –…
On-Demand Webinar
Accelerating GLP-1 Peptides to Market Through Integrated Formulation & Analytical Development
GLP-1 peptide therapeutics are rapidly reshaping the treatment landscape for diabetes and obesity, increasing the need for robust formulation development and comprehensive analytical characterization strategies that enable safe, scalable, and market-ready drug…
Industry Perspective
Supply chain resilience is not an insurance cost, but value protection
Supply chain resilience is not an insurance cost, but value protection Anurag Bhagania, Chief Financial Officer Published on BW CFO World, 14 Apr2026 For a long time, the ‘ideal’ supply chain was…
Industry Perspective
CDMOs as innovation partners in R&D
CDMOs as innovation partners in R&D Prateek Gupta, SVP & head, Technical Development Published on Hindustan Times, 22 Mar 2026 Pharma research and development (R&D) is moving faster and getting harder at…